Our Research

Research

At Houston Methodist, fostering innovations with the potential for clinical application is at the very heart of what we do. Our interdisciplinary teams of clinicians and researchers are committed to streamlining the process of translating discoveries into treatments and cures for our patients.

 

Learn more about how we are delivering on our commitment to leading medicine from the earliest phase of discovery in a lab to the testing new drugs or therapies in clinical trials.

 

Our Annual Report



$16 MILLION FEDERAL GRANT ADVANCES PRECISION PHARMACEUTICAL
DOD Feature Image

A Houston Methodist team led by Mauro Ferrari, PhD and Jenny Chang, MD has received funding from the U.S. Department of Defense to complete preclinical efficacy studies and a future clinical trial testing a breast cancer precision drug. Learn more.

 

Blood Test May Identify Cancer Patients at Risk for Brain Metastasis
Blood Vessel Feature Image

Houston Methodist researchers led by Dario Marchetti, PhD, have developed a blood test that can identify circulating tumor cells to predict breast cancer patients at risk for developing brain metastasis. Learn more.

 

RNA Therapy Reverses Effects of Aging in Progeria Cells
Cooke Feature Image

Houston Methodist scientists led by John Cooke, MD, PhD used telomerase mRNA technology to reverse senescence, rejuvenating aging human cells. Learn more.

Protein Protecting T-cells Aids in Destruction of Liver Immune Cells
Liver Feature Image

A Houston Methodist research team led by Xian Li, MD, PhD, identified the surface protein OX40 as a mediator of liver inflammation and disease. Learn more.

Latest News
Tuesday, April 10, 2018 Houston Methodist leads international clinical research for rare neurodegenerative disorder
A rare, inherited neurodegenerative disorder will soon be the focus of an international clinical research effort led by Houston Methodist and funded by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health.   Spinocerebellar ataxia (SCA) is characteri...
Read more
Monday, April 9, 2018 New study brings hope to liver cancer patients
Kandice Fogle, 43, had just moved to Houston when she began experiencing pain in her back and groin. After undergoing a CT scan, doctors found a large mass in her liver. A biopsy confirmed that she had intrahepatic cholangiocarcinoma, more commonly known as bile duct cancer.   After having the mass...
Read more